DARK.L Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 20:10):

Stats
Šios dienos apimtis	32.05M
Vidutinė apimtis	3.68M
Rinkos kapitalizacija	3.62B
EPS	£0 ( 2024-03-07 )
Kita pelno data	( £0 ) 2024-05-29
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	43.00
ATR14	£0.860 (0.14%)

Tūris Koreliacija

Ilgas: -0.08 (neutral)

Trumpas: -0.52 (weak negative)

Signal:(48.196) Neutral

Darktrace plc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos
IGEA.L	-0.831

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Darktrace plc Koreliacija - Valiuta/Žaliavos

-0.01
( neutral )

0.37
( neutral )

0.16
( neutral )

-0.57
( weak negative )

0.27
( neutral )

0.16
( neutral )

Darktrace plc Finansinės ataskaitos

Annual	2022
Pajamos:	£545.43M
Bruto pelnas:	£489.79M (89.80 %)
EPS:	£0.0893

FY	2022
Pajamos:	£545.43M
Bruto pelnas:	£489.79M (89.80 %)
EPS:	£0.0893

FY	2022
Pajamos:	£415.48M
Bruto pelnas:	£370.63M (89.21 %)
EPS:	£0.00200

FY	2021
Pajamos:	£281.34M
Bruto pelnas:	£252.89M (89.89 %)
EPS:	£-0.290

Financial Reports:

No articles found.

Darktrace plc

Darktrace plc, together with its subsidiaries, engages in the development and sale of cyber-threat defense technology solutions in the United Kingdom, the United States, Canada, Europe, and internationally. Its products include Enterprise Immune System to discover unpredictable cyber-threats; Industrial Immune System to detect novel threats and vulnerabilities, as well as safeguard the integrity and resilience of industrial technologies; and Cyber AI Analyst, an AI investigation technology, which automatically triages, interprets, and reports scope of security incidents. The company also provides Darktrace Antigena, an autonomous response technology for the enterprise with various security products that delivers proactive cyber defense to digital infrastructure. It serves critical national infrastructure organizations, financial services companies, technology and healthcare providers, media corporations, and educational institutions. The company was founded in 2013 and is headquartered in Cambridge, the United Kingdom.